HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leland W K Chung Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

9/2014RANK-mediated signaling network and cancer metastasis.
7/2006Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
1/2006Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells.
1/2005Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.
3/2004Modulation of prostate cancer growth in bone microenvironments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leland W K Chung Research Topics

Disease

106Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2002
89Neoplasms (Cancer)
06/2023 - 01/2002
46Neoplasm Metastasis (Metastasis)
01/2022 - 01/2002
8Hypoxia (Hypoxemia)
10/2014 - 01/2006
7Circulating Neoplastic Cells
01/2019 - 03/2011
5Breast Neoplasms (Breast Cancer)
01/2022 - 04/2013
5Carcinoma (Carcinomatosis)
01/2013 - 04/2003
4Renal Cell Carcinoma (Grawitz Tumor)
06/2023 - 12/2006
4Disease Progression
11/2018 - 04/2011
3Kidney Neoplasms (Kidney Cancer)
06/2023 - 02/2013
3Brain Neoplasms (Brain Tumor)
01/2019 - 10/2015
3Starvation
01/2013 - 05/2007
2Lung Neoplasms (Lung Cancer)
12/2021 - 02/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 07/2007
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2009 - 10/2004
2Osteosarcoma (Osteogenic Sarcoma)
09/2007 - 01/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021

Drug/Important Bio-Agent (IBA)

38AndrogensIBA
01/2021 - 01/2002
30Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2002
17Androgen Receptors (Androgen Receptor)IBA
01/2019 - 06/2002
12Coloring Agents (Dyes)IBA
06/2023 - 05/2010
12Transcription Factors (Transcription Factor)IBA
12/2018 - 01/2002
12Hormones (Hormone)IBA
01/2016 - 01/2002
11Biomarkers (Surrogate Marker)IBA
09/2015 - 08/2004
11Prostate-Specific Antigen (Semenogelase)IBA
11/2011 - 06/2002
9CarbocyaninesIBA
06/2023 - 02/2013
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2007
8LigandsIBA
12/2016 - 08/2004
8AntibodiesIBA
09/2016 - 03/2004
8OsteocalcinIBA
12/2007 - 01/2002
7Peptides (Polypeptides)IBA
12/2021 - 05/2010
7ElementsIBA
03/2016 - 11/2003
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2014 - 01/2006
6AnionsIBA
12/2021 - 05/2010
5Fluorescent Dyes (Fluorescent Probes)IBA
12/2021 - 01/2008
5MicroRNAs (MicroRNA)IBA
01/2019 - 11/2008
5Thymidine KinaseIBA
01/2019 - 02/2003
5Matrix Metalloproteinases (MMPs)IBA
01/2017 - 03/2004
5LuciferasesIBA
01/2016 - 01/2002
5Small Interfering RNA (siRNA)IBA
10/2014 - 09/2006
5IntegrinsIBA
09/2014 - 03/2004
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014 - 03/2004
5Cadherins (E-Cadherin)IBA
03/2014 - 12/2006
5Conditioned Culture MediaIBA
07/2010 - 03/2005
4Cisplatin (Platino)FDA LinkGeneric
06/2023 - 01/2019
4Monoamine Oxidase (MAO)IBA
01/2019 - 07/2014
4Messenger RNA (mRNA)IBA
10/2014 - 10/2005
4MHI-148IBA
10/2014 - 05/2010
3Ganciclovir (Cytovene)FDA LinkGeneric
01/2019 - 02/2004
3ProdrugsIBA
01/2019 - 02/2004
3OsteonectinIBA
01/2019 - 12/2011
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2017 - 10/2006
3heptamethine cyanine dyeIBA
01/2017 - 05/2010
3VimentinIBA
09/2016 - 12/2006
3Liposomes (Liposome)IBA
10/2014 - 10/2005
3EnzymesIBA
07/2014 - 01/2013
3AntigensIBA
03/2014 - 01/2007
3IronIBA
03/2014 - 04/2011
3IR-783IBA
01/2014 - 05/2010
3PolymersIBA
06/2013 - 08/2004
3Tumor Biomarkers (Tumor Markers)IBA
01/2011 - 03/2004
3Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2006 - 03/2005
3Cyclic AMP (AMP, Cyclic)IBA
12/2006 - 03/2005
3Carrier Proteins (Binding Protein)IBA
12/2006 - 03/2005
3Heparin (Liquaemin)FDA LinkGeneric
07/2006 - 01/2005
2Keratin-13 (Keratin 13)IBA
01/2022 - 12/2016
2Cyclin D1IBA
01/2021 - 09/2006
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2018 - 03/2013
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 09/2009
2perlecanIBA
03/2016 - 01/2005
2Docetaxel (Taxotere)FDA Link
12/2015 - 04/2007
2Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
09/2014 - 08/2008
2CateninsIBA
03/2014 - 01/2012
2Metalloproteases (Metalloproteinases)IBA
01/2013 - 12/2012
2DisintegrinsIBA
01/2013 - 12/2012
2Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2013 - 04/2003
2Integrin alphaVIBA
01/2010 - 10/2005
2ChemokinesIBA
11/2009 - 09/2009
2Phosphotransferases (Kinase)IBA
06/2009 - 12/2006
2Neutralizing AntibodiesIBA
07/2007 - 01/2006
2Integrin-Binding SialoproteinIBA
09/2006 - 03/2005
2NF-kappa B (NF-kB)IBA
07/2005 - 04/2004
2Cholecalciferol (Vitamin D3)FDA Link
03/2005 - 06/2002
2Acyclovir (Aciclovir)FDA LinkGeneric
03/2004 - 02/2004
1Cytochromes c (Cytochrome c)IBA
06/2023
1CaspasesIBA
06/2023
1gamma Catenin (Plakoglobin)IBA
01/2022
1Simvastatin (Zocor)FDA LinkGeneric
12/2021
1CholesterolIBA
12/2021

Therapy/Procedure

27Therapeutics
06/2023 - 01/2002
14Castration
01/2022 - 07/2010
8Quantum Dots (Quantum Dot)
01/2022 - 08/2004
6Drug Therapy (Chemotherapy)
06/2023 - 03/2004
3Precision Medicine
01/2021 - 09/2013
3Subcutaneous Injections
06/2017 - 08/2004
2Prostatectomy (Retropubic Prostatectomy)
10/2019 - 07/2010
2Intravenous Administration
01/2016 - 11/2003
2Injections
04/2013 - 11/2006
2Radiotherapy
01/2013 - 11/2008
2Semiconductors
01/2007 - 08/2004